When was RxAnte founded?

RxAnte was founded in 2011 and raised its 1st funding round 1 year after it was founded.

Where is RxAnte located?

RxAnte is headquartered in Mclean, United States. It is registered at Portland, Maine.

How many employees does RxAnte have?

As of Jul 31, 2026, the latest employee count at RxAnte is 93.

Is RxAnte a funded company?

RxAnte is a funded company, having raised a total of $15.5M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Sep 12, 2012.

When was the latest funding round of RxAnte?

RxAnte's latest funding was a $***** PE round on Jan 12, 2026, with participation from 1 investor.

Where does RxAnte rank among its competitors?

RxAnte ranks 1st amongst 35 active competitors, of which 5 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was RxAnte, which secured an undisclosed amount in Jan, 2026.

Who are the top competitors of RxAnte?

RxAnte's top competitors include AdhereHealth, DayaMed and Health Espresso. Among them, RxAnte secured the most recent funding round in January, 2026.

RxAnte - 2026 Company Profile, Team, Funding & Competitors

RxAnte is an acquired company based in Mclean (United States), founded in 2011 by Aaron McKethan and Loren Lidsky. It operates as a Pharmacy care management solutions improving medication use, quality, and cost. RxAnte has raised $15.5M in funding from Aberdare Ventures and West Health. The company has 35 active competitors, including 5 funded and 3 that have exited. Its top competitors include companies like AdhereHealth, DayaMed and Health Espresso.

Company Details

Pharmacy care management solutions improving medication use, quality, and cost. The company partners with health plans and providers, offering innovative Pharmacy Care Management (PCM) programs. These programs enhance care quality while reducing healthcare costs. As a pioneer in tech-enabled, value-based pharmacy care management, the company provides tailored solutions to address the unique needs of health plans and their at-risk members. Their platform drives pharmacy quality improvement through digital tools and insights, helping health plans optimize pharmacy performance and meet quality goals. They also offer value-based pharmacy care management with comprehensive, tech-enabled services designed to support high-risk members with personalized care. The company utilizes patented analytics and software to select the intervention most likely to benefit each at-risk individual. They engage at-risk members with existing care managers, activate provider networks, or use a curated network of patient engagement vendors.

Website: www.rxante.com/
Social
Email ID: *****@rxante.com
Registered Address: Portland, Maine

Key Metrics

Founded Year

2011

Location

Mclean, United States

Stage

Acquired

Total Funding

$15.5M in 5 rounds

Latest Funding Round

PE, Jan 12, 2026, $*****

Investors

Aberdare Ventures & 4 more

Ranked

1^st among 35 active competitors

Employee Count

93 as on Jul 31, 2026

Similar Companies

AdhereHealth & 41 more

Exit Details

Acquired by UPMC (Oct 06, 2016)

View RxAnte's full profile

RxAnte is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Rxante, Inc. CIN: 454040219 , United States, Active	Dec 31, 1999	-	100 (As on Dec 31, 2024)	-
RxAnte, Inc. CIN: 20141096569 , United States, Active	Feb 12, 2014	$1 - $1M (As on Sep 12, 2012)	-	-

RxAnte got acquired by UPMC on Oct 06, 2016.

Click here to take a look at RxAnte's acquisition in detail

RxAnte has raised a total funding of $15.5M over 5 rounds. Its first funding round was on Sep 12, 2012. Its latest funding round was a PE round on Jan 12, 2026 for $*****. 1 investor participated in its latest round. RxAnte has 5 institutional investors.

Here is the list of recent funding rounds of RxAnte:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 12, 2026	3016335	PE	9444580	2646527	1981104	4964727
Dec 21, 2022	1730052	Venture Debt	1221702	2051514	8726383	Trinity Capital
May 13, 2022	4242169	Series B	2720604	1056046	3050176	4968121

Access funding benchmarks and valuations. Sign up today!

View details of RxAnte's funding rounds and investors

The founders of RxAnte are Aaron McKethan and Loren Lidsky.

Here are the details of RxAnte's key team members:

Aaron McKethan: Former Co-Founder of RxAnte and founder of 2 other companies, NoviSci and Aberdare Ventures.
Contact Info: 1 email address
Loren Lidsky: Co-Founder of RxAnte.
Contact Info: 1 email address
Joshua Benner: CEO of RxAnte.

View details of RxAnte's Founder profiles and Board Members

RxAnte's employee count trend

RxAnte has 93 employees as of Jul 26. Here is RxAnte's employee count trend over the years:

Uncover RxAnte's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of RxAnte include AdhereHealth, DayaMed and Health Espresso. Here is the list of Top 10 competitors of RxAnte, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	RxAnte 2011, Mclean (United States), Acquired	Pharmacy care management solutions improving medication use, quality, and cost	$15.5M	Trinity Capital, Primus Capital & 3 others	62/100
2nd	AdhereHealth 2006, Franklin (United States), Acquired	Provider of medication adherence platform for healthcare professionals and patients	$8.8M	Riverside Management Group, Oxeon Partners	53/100
3rd	DayaMed 2014, Waterloo (Canada), Unfunded	Provider of medication adherence platform for healthcare organisations	-	-	42/100
4th	Health Espresso 2016, Oakville (Canada), Unfunded	Provider of medication adherence platform for healthcare professionals	-	-	39/100
5th	AllazoHealth 2011, New York City (United States), Seed	Tech-enabled solutions optimizing specialty pharmaceutical access, affordability, and adherence	$120K	New York Digital Health, Blueprint Health	39/100
6th	Clarity Group 2001, United States, Funding Raised	Provider of healthcare risk management software and patient safety reporting solutions	-	Volaris Group, OSTI	38/100
7th	ActualMeds 2009, East Hartford (United States), Series A	Medication management solutions improving adherence, reducing hospitalizations, and optimizing patient outcomes	$4.08M	New York Digital Health, Springboard Enterprises ... & 2 others	36/100
8th	DrugStars 2016, Ballerup (Denmark), Deadpooled	Provider of an app for reward-based patient medication adherence record management	$1.03M	PreSeed Ventures, Seed Capital & 8 others	32/100
9th	Pilleve 2017, Winston-salem (United States), Seed	Platform for monitoring and screening opioid abuse	$150K	500 Global, One Way Ventures & 7 others	31/100
10th	RxMx 2012, Sydney (Australia), Unfunded	Provider of medication management platform	-	-	31/100